W STRATEGIES, LLC for ABBOTT LABORATORIES
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Development of reauthorizing legislation implementing the Prescription Drug User Fee Act (PDUFA) and Medical Device User Fee Act agreements and related issues. Federal legislative efforts to enhance the security and integrity of the domestic pharmaceutical distribution system.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
H.R. 452: Medicare Decisions Accountability Act. Education on the importance of maintaining the competitive elements of the Part D prescription drug program and to oppose efforts to impose mandatory government rebates in that program. H.R. 3497: Moddern Cures Act as it relates to reimbursement of diagnostics. H.R. 5: Help Efficient, Accessible, Low-cost Timely Healthcare Act. H.R. 452: Medicare Decisions Accountability Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Budget/Appropriations BUD
H. Con. Res. 112: FY 2013 Budget Resolution. Education regarding the importance of maintaining current law as it relates to biosimilars and opposing efforts in the President's Budget to shorten the term of data exclusivity for innovator biologics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Taxation/Internal Revenue Code TAX
H.R. 436: Protect Medical Innovation Act. Monitoring H.R. 3630: Middle Class Tax Relief and Job Creation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.